Stand aside — setup invalidated
Setup score 68, but distribution days reach 5 or more — stand aside until the condition resets.
Simple research view
ABBV · AbbVie Inc.
$255.00 +1.63% Sep 10 close
1 independent risk warning also present. Review before relying on the bullish setup.
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$ABBV
AbbVie Inc.AbbVie Inc. is a mega-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $451B.
⚠ Risk Signals
Bearish RSI Divergence
Price higher high ($261.07→$265.97) but RSI lower high (77→67) — momentum diverging
Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.
Verdict · setup score 68/100 · data Sep 10 close · 1 session old
Stand aside — setup invalidated
Setup score 68, but distribution days reach 5 or more — stand aside until the condition resets.
Earnings
Normal technical setup
No sourced report date
Event risk is not modelled for this symbol
Deterministic evidence
ABBV+1.63%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Session internals Strong momentum
Rule: closed up, at or above the open, in the top third of the day's range. Judged on internals, not on the size of the move.
Vs prior close+1.63%
From the open+1.09%
Range position94%
GapNo gap
QQQ confirmationDiverging (-1.06%)
SMH confirmationDiverging (-2.44%)
Short-term conviction -1 points.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.
- QQQ, SMH moved against the stock — no index confirmation.
Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.
More stats
52W Low
$190.75
Tight Wks
1
Base
B1
SMA 200
$228.63
RS Line vs High
-8.0%
RS Line Slope
+4.4% ▲
Group Rank
#27/58
ADR%
2.0%
ATR(14)
$5.46 (2.1%)
Vol Pace (live)
N/A
U/D Vol
0.73
A/D Days
13A / 16D
A/D Rating
E
VDU Bars
0/10 d
ABBV Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Technical Analysis Report Card
$ABBV · $255.00 · as of 2026-09-10 · multi-factor read
68
/ 100
Reference read from price & volume only — the verdict at the top of the page decides the action.
Trend · Daily / Weekly / Monthly
Daily
▬ Sideways / consolidating
Weekly
▲ Uptrend
Monthly
▲ Uptrend
Moving Averages
50-day$254.39 ↑
100-day$235.47 ↑
200-day$228.63 ↑
Bullish (50 > 200)
RSI (14)
Reading49.5 · Neutral
Neutral — momentum is balanced between buyers and sellers.
MACD (12/26/9)
StateWeakening
Histogram-1.303
Weakening — MACD slipped below its signal line. Histogram expanding.
Bollinger Bands (20,2)
%B / Width37% · 8.8%
Squeeze — volatility compressing
Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.
Volume · Buyer vs Seller
Up/Down vol0.73 · Neutral
Rel volume0.84×
Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.
Support & Resistance
R · $261.30swing level
R · $267.2252-week high
Price · $255.00now
S · $242.13swing level
S · $221.12swing level
S · $215.37swing level
Fibonacci · Uptrend swing
23.6%$249.36
38.2%$238.16
50.0%$229.11
61.8%$220.06
78.6%$207.17
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for ABBV — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice?
Ask a Legend about ABBV
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B
Trend-template read: 8/10 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $255.00, MA150 $230.01, MA200 $228.63
1.2 150-day MA > 200-day MAMA150 $230.01 vs MA200 $228.63
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 40
2. Revenue growth ≥ 20% YoY+8.6% YoY
Avoid
O'Neil D
CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).
Passing evidence
C: Quarterly EPS acceleration ≥ 25%+37.7% QoQ
A: Annual earnings & revenue qualityRev +8.6% | ROE 95.6%
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 40
S: Volume ≥ 40% above average on breakoutVolume ratio 0.84x
Watch
Weinstein C
Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $255.00 vs MA200 $228.63
Failing evidence
Volume expansion above averageVolume ratio 0.84x
Relative strength ≥ 60RS 40
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$255.00
Distance from 52-week high4.7% below high
Failing evidence
Relative strengthRS 40
Volume vs average0.84x
Watch
Darvas B
Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$255.00
Distance from 52-week high4.7% below high
Failing evidence
Relative strengthRS 40
Volume vs average0.84x
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$255.00
Distance from 52-week high4.7% below high
Failing evidence
Relative strengthRS 40
Volume vs average0.84x
Base & Breakout
Breakout follow-through
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▲ Rising
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net +1
Fundamentals & leadership quality — Minervini’s published criteria · 5/7 met
B
5/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+38%
Revenue growth ≥20% YoY
+9%
Gross margin ≥30%
73%
ROE ≥17%
96%
RS rating ≥80 (leadership)
40
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-4.7%
Method Playbook
Trade it like Livermore
EXACT LEVELS · PRO
Livermore B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro levelPublished-method rule: Treat the resistance break as a pivotal point only while the primary trend and relative strength remain aligned.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Wait for price and volume to confirm the pivotal-point break; anticipation below the line is not confirmation.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Place the initial stop below the pivotal line or the reaction low that would prove the breakout false.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Raise protection beneath successive higher reaction lows as the trend advances; never move a protective line farther away.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit when price fails the pivotal line, breaks the latest meaningful reaction low, or shows abnormal reversal action.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis
68
setup score
RS Score
40
Trend template
7/8
Why This Setup?
Trend Only · schematic
Gatekeeper 7/8 | Strong trend (7/8) | Stage 2
The Universal Edge Check · context only
What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.
1/7
universals met
- A relative-strength leader — not met RS rank 31 — laggard
- Risk is defined — not met No stop — undefined risk
- Asymmetric reward — partly met No target set
- Clear of earnings — partly met Report date unknown
- Not chasing (in range) — partly met Pivot distance unknown
- Volume confirms — partly met 0.8× average — light
- In a confirmed uptrend — met Stage 2 · Trend template 7/8
Minervini Trend Template
7/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$255.00 vs SMA150 $230.01 / SMA200 $228.63
SMA 150 above SMA 200
SMA150 $230.01 vs SMA200 $228.63
SMA 200 trending up
Slope +3.24 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $254.39
Price above SMA 50
$255.00 vs SMA50 $254.39
30%+ above 52-week low
+33.7% from $190.75
Within 25% of 52-week high
-4.7% from $267.47
RS score above 70
RS 40
Fundamentals
52W Range
84%
Mkt Cap SEC
450.6B
EPS QoQ
+38%
Rev YoY
+9%
ROE
96%
Gross Margin
73%
D/E
20.19
EPS TTM
$2.36
P/E TTM
108.1x
Float
1.8B
Company
Company profile
AbbVie Inc.
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
7/8
W. RS
68
W. Support
$190.75
W. Resist
$267.47
Weekly Structure
Trend
Neutral
Tight Weeks
1
Confirmation
Neutral
Scan History
9× streakSep 11
Trend Only
✓ Gate
68
Sep 11
Trend Only
✓ Gate
68
Sep 11
Trend Only
✓ Gate
67
Sep 11
Trend Only
✓ Gate
65
Sep 10
watchlist_candidate
0
0.0%
Sep 08
Trend Only
✓ Gate
65
+2.5%
Get the full picture on ABBV
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.
Start 7-Day Free Trial